KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $677.9 million.

  • Eli Lilly's Free Cash Flow fell 3066.38% to $677.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.0 billion, marking a year-over-year increase of 13861.7%. This contributed to the annual value of $9.0 billion for FY2025, which is 13861.7% up from last year.
  • According to the latest figures from Q4 2025, Eli Lilly's Free Cash Flow is $677.9 million, which was down 3066.38% from $6.7 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Free Cash Flow ranged from a high of $6.7 billion in Q3 2025 and a low of -$1.4 billion during Q4 2023
  • Moreover, its 5-year median value for Free Cash Flow was $1.2 billion (2022), whereas its average is $1.3 billion.
  • Its Free Cash Flow has fluctuated over the past 5 years, first soared by 102578.57% in 2021, then crashed by 21901.89% in 2023.
  • Quarter analysis of 5 years shows Eli Lilly's Free Cash Flow stood at $2.0 billion in 2021, then crashed by 41.02% to $1.2 billion in 2022, then tumbled by 219.02% to -$1.4 billion in 2023, then soared by 170.69% to $977.7 million in 2024, then crashed by 30.66% to $677.9 million in 2025.
  • Its Free Cash Flow was $677.9 million in Q4 2025, compared to $6.7 billion in Q3 2025 and $1.4 billion in Q2 2025.